Search PDMR transactions

Notifier
Name of person with notification obligation
Martin Jönsson
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Martin Jönsson
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
No
Amendment
Yes
Details of amendment
Angav fel emittent, vilket jag nu korrigerat.
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
AlzeCure Pharma AB
Issuer´s LEI code
5493001EJLEBXFY6I446
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA AlzeCure Pharma AB SE0010133785 Subscription 40,800 Quantity 4.00 SEK 22/03/2022 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
AlzeCure Pharma AB SE0010133785 Subscription 22/03/2022 NASDAQ STOCKHOLM AB 40,800 (Quantity) 4.00 SEK
Total: 40,800
<< Back